-+ 0.00%
-+ 0.00%
-+ 0.00%

Actinium Pharmaceuticals Names Matt David Chief Financial Officer

PUBT·11/17/2026 12:02:31
Listen to the news
Actinium Pharmaceuticals Names Matt David Chief Financial Officer
  • Actinium Pharmaceuticals appointed Matt David chief financial officer, bringing over 20 years of finance experience, most recently at CorMedix.
  • Sean Maenpaa was named senior vice president of business development, bringing radiopharmaceutical experience from Bayer, Clovis Oncology and Telix Pharmaceuticals.
  • A newly formed scientific advisory board brings together five experts in prostate cancer, hematologic malignancies, radiochemistry and nuclear medicine.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611170700PR_NEWS_USPR_____NY99496) on November 17, 2026, and is solely responsible for the information contained therein.